US2014154236A1PendingUtilityA1

Devices and methods for treating pain associated with tonsillectomies

51
Assignee: INTERSECT ENT INCPriority: Apr 27, 2009Filed: Feb 6, 2014Published: Jun 5, 2014
Est. expiryApr 27, 2029(~2.8 yrs left)· nominal 20-yr term from priority
A61B 17/06166A61M 31/002A61B 2090/3987A61L 31/16A61B 2017/0641A61B 2017/0649A61B 2017/0647A61B 17/064A61B 17/08A61B 2017/06176A61B 2017/00893A61B 17/26A61B 2017/0073A61B 17/068A61L 17/10A61M 37/0069A61B 17/3468A61B 17/083A61B 17/04A61B 2090/3991A61B 17/0644A61M 31/00
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Described here are devices and methods for treating one or more conditions or symptoms associated with a tonsil procedure. In some variations, a drug-releasing device may be at least partially delivered to one or more tonsillar tissues before, during, or after a tonsil procedure. In some variations, the drug-releasing device may be configured to be biodegradable. In other variations, the drug-releasing device may comprise one or more hemostatic materials or one or more adhesives. The drug-releasing device may be configured to release one or more drugs or agents, such as, for example, one or more analgesics, local anesthetics, vasoconstrictors, antibiotics, combinations thereof and the like.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A method for treating a patient comprising:
 performing a tonsil procedure; and   at least partially delivering at least one drug-releasing implant to tonsillar tissue of the patient.   
     
     
         2 . The method of  claim 1  wherein the at least one drug-releasing implant comprises at least one polymer filament. 
     
     
         3 . The method of  claim 2  wherein the at least one polymer filament comprises one or more anchoring features that impair removal of the at least one polymer filament from the tonsillar tissue. 
     
     
         4 . The method of  claim 3  wherein the anchoring features comprises one or more notches in a surface of the at least one polymer filament. 
     
     
         5 . The method of  claim 3  wherein the anchoring feature comprises one or more barbs or prongs. 
     
     
         6 . The method of  claim 1  wherein the at least one drug-releasing implant comprises a suture. 
     
     
         7 . The method of  claim 1  wherein the at least one drug-releasing implant comprises a plurality of space-filling implants. 
     
     
         8 . The method of  claim 7  wherein the plurality of space-filling implants comprise one or more fibrin glue components. 
     
     
         9 . The method of  claim 1  further comprising covering at least a portion of the tonsillar tissue with one or more films, sheets, meshes, or patches. 
     
     
         10 . The method  claim 1  wherein the one or more drug-releasing implant comprises a clip, and wherein the clip comprises a surface member and at least one anchoring member. 
     
     
         11 . The method of  claim 1  further comprising affixing a tissue-restraining device to the tonsillar tissue. 
     
     
         12 . The method of  claim 1  wherein the at least one drug-releasing implant is configured to release an anti-inflammatory. 
     
     
         13 . The method of  claim 1  wherein the at least one drug-releasing implant is configured to release an antibiotic. 
     
     
         14 . The method of  claim 1  wherein the at least one drug-releasing implant is configured to release a painkiller or local anesthetic. 
     
     
         15 . The method of  claim 1  wherein the at least one drug-releasing implant is biodegradable. 
     
     
         16 . The method of  claim 1  wherein the at least one drug-releasing implant comprises a polymer. 
     
     
         17 . The method of  claim 1  wherein the tonsil procedure is a tonsillectomy or an adenoidectomy. 
     
     
         18 . The method of  claim 17  wherein the tonsillar tissue comprises a tonsillar bed. 
     
     
         19 . The method of  claim 1  wherein the at least one drug-releasing implant comprises an adhesive. 
     
     
         20 . The method of  claim 19  wherein the adhesive is a fibrin glue.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.